Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney Disease

BACKGROUND: Roux-en-Y gastric bypass surgery (RYGB) improves biochemical and histological parameters of diabetic kidney disease (DKD). Targeted adjunct medical therapy may enhance renoprotection following RYGB. METHODS: The effects of RYGB and RYGB plus fenofibrate, metformin, ramipril, and rosuvast...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, William P., Chuah, Yeong H. D., Abdelaal, Mahmoud, Pedersen, Anders, Malmodin, Daniel, Abrahamsson, Sanna, Hutter, Michaela, Godson, Catherine, Brennan, Eoin P., Fändriks, Lars, le Roux, Carel W., Docherty, Neil G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867227/
https://www.ncbi.nlm.nih.gov/pubmed/35222262
http://dx.doi.org/10.3389/fendo.2021.757228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867227/
https://www.ncbi.nlm.nih.gov/pubmed/35222262
http://dx.doi.org/10.3389/fendo.2021.757228

Ejemplares similares